{
    "clinical_study": {
        "@rank": "67160", 
        "arm_group": [
            {
                "arm_group_label": "Oxytocin", 
                "arm_group_type": "Experimental", 
                "description": "24 IU Oxytocin, intranasal application 30 min prior to the experiment"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "intranasal application, sodium chloride solution, 3 puffs per nostril"
            }
        ], 
        "brief_summary": {
            "textblock": "Social touch can convey the most potent and salient of socio-emotional signals. While the\n      hypothalamic peptide oxytocin (OXT) has been identified as a key neurochemical mediator of\n      grooming in some other social species, its modulatory influence on human interpersonal touch\n      is unknown. The investigators expect that OXT augments the hedonic value of touch and that\n      this behavioral effect is paralleled at the neural level by an increased response in brain\n      areas mediating rewarding aspects of social touch."
        }, 
        "brief_title": "The Influence of Oxytocin on the Processing of Social Contact", 
        "completion_date": {
            "#text": "August 2013", 
            "@type": "Actual"
        }, 
        "condition": "Healthy Male Volunteers", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Healthy male volunteers\n\n        Exclusion Criteria:\n\n        Current or past psychiatric disease Current or past physical illness Psychoactive\n        medication Tobacco smokers"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 27, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01939639", 
            "org_study_id": "OXT_PS_2013", 
            "secondary_id": "PS_2013"
        }, 
        "intervention": [
            {
                "arm_group_label": "Placebo", 
                "description": "intranasal application, sodium chloride solution, 3 puffs per nostril", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug", 
                "other_name": "Placebo"
            }, 
            {
                "arm_group_label": "Oxytocin", 
                "description": "24 IU Oxytocin, intranasal application 45 min prior to the experiment", 
                "intervention_name": "Oxytocin", 
                "intervention_type": "Drug", 
                "other_name": "Syntocinon"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Oxytocin"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Oxytocin", 
            "fMRI"
        ], 
        "lastchanged_date": "September 5, 2013", 
        "link": {
            "url": "http://renehurlemann.squarespace.com/welcome/"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Bonn", 
                    "country": "Germany", 
                    "state": "North Rhine-Westphalia", 
                    "zip": "53105"
                }, 
                "name": "Department of Psychiatry, University of Bonn"
            }
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "2", 
        "other_outcome": {
            "measure": "Saliva oxytocin concentrations", 
            "safety_issue": "No", 
            "time_frame": "15 minutes before the nasal spray administration and (on average) 10 minutes after the fMRI experiment"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Germany: Ethics Commission", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "After each trial, subjects are asked to use a visual analog scale to rate the pleasantness of the administered touch.", 
                "measure": "Pleasantness ratings of social touch", 
                "safety_issue": "No", 
                "time_frame": "30 minutes after the nasal spray administration"
            }, 
            {
                "description": "By using functional magnetic resonance imaging we want to examine oxytocin's effects on the neural correlates (BOLD signal) of social touch.", 
                "measure": "Blood-oxygen-level dependent signal in response to social touch", 
                "safety_issue": "No", 
                "time_frame": "30 minutes after the nasal spray administration"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01939639"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University Hospital, Bonn", 
            "investigator_full_name": "Rene Hurlemann", 
            "investigator_title": "MD PhD M.Sc.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Questionnaire measurement of mood (PANAS) and anxiety (STAI).", 
            "safety_issue": "No", 
            "time_frame": "15 minutes before the nasal spray administration and (on average) 10 minutes after the fMRI experiment"
        }, 
        "source": "University Hospital, Bonn", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital, Bonn", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}